Lecanemab (Leqembi®) and donanemab (Kisunla®) are two new FDA-approved drugs, administered intravenously, that can slow cognitive decline in people diagnosed with early-stage Alzheimer’s. While not a cure, they can slow...
Podcasts
The HEALTH Yeah! podcast from Stony Brook Medicine features expert discussions on a wide range of health-related topics, including wellness tips, disease prevention and diagnosis, mental health awareness and surgical interventions.
The Healthcast podcast features leaders and experts from Stony Brook Medicine who come together to discuss a range of topics, from leadership and strategic planning to patient care and the inner workings of a successful healthcare system.
Copyright © 2026. Stony Brook Medicine